Bio-Thera And BeiGene Partner For Bevacizumab In China

Partnered Territory Includes Hong Kong, Macau and Taiwan

 
• By Akriti Seth

Bio-Thera is collaborating with BeiGene for BAT1706, a biosimilar to Avastin (bevacizumab), to develop, manufacture and commercialize the product in Greater China.

Business_China
Bio-Thera and BeiGene collaborate for bevacizumab in China, including Hong Kong, Macau and Taiwan. • Source: Shutterstock

More from Biosimilars

More from Products